DL
David Liu
CEO
About
Comments
No comments yet. Be the first to share your take.
Frequently asked
What is David Liu's current role?
David Liu is currently CEO.
Profile
About David Liu
David Liu is CEO. David is a founder of Sonde Health, Hexagon Bio, Kelda, VI Therapeutics, and Arrakis Bio. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.
Founder of
- Sonde HealthAI-powered vocal biomarker platform for early detection and monitoring of health conditions.
- Hexagon BioDeveloping novel therapeutics by understanding the complex interplay of biological systems.
- KeldaConnect your meds, labs, symptoms and wearable data to how you actually feel.
- VI TherapeuticsVI Therapeutics is developing novel therapies for rare genetic diseases.
- Arrakis BioArrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.